Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous ESPB for Analgesia and Pulmonary Function in Rib Fractures
NCT04558281Phase 4Terminated
- Sponsor
- University of California, San Diego
- Start
- May 2021
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of ropivacaine in rib fracture, sponsored by University of California, San Diego. Primary endpoint: Maximal Inspired Volume - Absolute at 1 day. Started May 2021; status: terminated.
02
Drugs
ropivacaine
03
Conditions
rib fracture
Beyond the preview
Go deeper on NCT04558281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04558281.